Navigation Links
Jean-Pol Tassin wins the 2009 ECNP Neuropsychopharmacological Award
Date:9/23/2009

The European College of Neuropsychopharmacology (ECNP) is pleased to announce Jean-Pol Tassin as the recipient of the 2009 ECNP Neuropsychopharmacology Award in Basic Science Research in recognition of his pioneering and innovative research into the neurochemical basis of substance addiction.

The ECNP Neuropsychopharmacology Award recognises outstanding research in the field of neuropsychopharmacology and its closely related disciplines. Granted annually, the award alternates between basic science and clinical research and is accompanied by a prize of EUR 20,000. Jean-Pol Tassin Tassin is the award's 31st recipient.

Jean-Pol Tassin, currently team leader at the Collge de France's Molecular Genetic, Neurophysiology and Behaviour Laboratory in Paris, was drawn to addiction by his early research on nerve terminals in the prefrontal cortex and the effects of stress and long-term isolation on the meso-cortical pathway. Moving to studies on the impact of psychostimulants on cortical and sub-cortical neurons, his critical insight was to connect the disruption of nonadrenaline and serotonin neuron interaction with addictive behaviour. Jean-Pol Tassin's research showed how these neurons, when exposed to repeated psychostimulant abuse, become 'uncoupled,' thereby inducing distress, or withdrawal, for which further administrations of the drug are needed to achieve relief. Later refinements to this groundbreaking model have highlighted the key role played in tobacco addiction by monoamine inhibitors present in cigarettes.

Presenting the award at the 22nd ECNP Congress in Istanbul, the chairman of the ECNP Award Jury 2009, Tomas Hkfelt of the Karolinska Institute in Stockholm, commended Tassin's scientific originality as well as his landmark contribution to our understanding of this critical public health concern.


'/>"/>

Contact: Sonja Mak
s.mak@update.europe.at
431-405-5734
European College of Neuropsychopharmacology
Source:Eurekalert

Page: 1

Related biology news :

1. ESF EURYI award winner aims to stop cancer cells reading their own DNA
2. The American Society of Plant Biologists announces 2007 awards
3. Minimally invasive heart surgery research wins NIH award
4. 12 McGill researchers awarded Canada Research Chairs
5. Herr receives Heinz Award for Technology, the Economy and Employment
6. Singapore National Science and Technology Awards
7. RSC Project Prospect scoops prestigious award
8. Springer book wins Quality of Communication Award
9. Homeland Security awards 2 grants to Rutgers for nuclear threat detection
10. NIH awards nearly $23M to University of Chicago for translational research
11. NIH awards researcher $1.5 million new innovator grant for fruit-fly studies of prion proteins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... West Orange, NJ. August 27, 2014. Using functional ... shown differential brain activation patterns between people with ... the first MS study in which brain activation ... cognitive task. The article, "Neuroimaging and cognition using ... was published online on June 11 by ...
(Date:8/27/2014)... have identified a gene that could help scientists engineer ... in the cell membrane of plants that senses changes ... machinery accordingly. , "It,s similar to a thermostat," ... Duke. , The findings, which appear Aug. 28 ... easier to feed the world,s growing population in the ...
(Date:8/27/2014)... of the HIV drug maraviroc, a new study from ... the drug was licensed in 2007, included mostly European-Americans, ... removing maraviroc from the body. The current study shows ... including nearly half of African-Americans end up with ... lack the protein even when given the same dose. ...
Breaking Biology News(10 mins):Kessler Foundation researchers publish first study of brain activation in MS using fNIRS 2Water 'thermostat' could help engineer drought-resistant crops 2Dosage of HIV drug may be ineffective for half of African-Americans 2
... one scratchy tune learned in its youth, which it ... occasionally, the finch might improvise, experimenting with a slower, ... studying the finch now say the improvisation arises from ... section of the forebrain that seems to generate the ...
... in St. Louis have discovered an entirely new cellular ... plant flowering and DNA methylation, a key chemical process ... by Craig Pikaard, Ph, D., Washington University professor of ... kind of RNA polymerase found only in plants and ...
... (CLL) is an incurable disease in which cells in the ... become abnormal and malignant (leukemic). The progression of the disease ... regarding the rate of production of CLL cells, and the ... believed that CLL was a static disease of long-lived lymphocytes ...
Cached Biology News:Bird Brains Show How Trial and Error May Contribute to Learning 2Bird Brains Show How Trial and Error May Contribute to Learning 3New RNA polymerase discovered in plants 2New RNA polymerase discovered in plants 3The very unexpected life and death of a leukemic cell 2
(Date:8/28/2014)... PARK, Calif. , Aug. 28, 2014 /PRNewswire/ ... focused on developing novel mid- to late-stage cardiovascular ... $7.0 million in its first round of financing. ... Biomedical Investments and Hercules Bioventures with participation from ... entrepreneur and pharmaceutical executive, Dr. Larry Hsu ...
(Date:8/28/2014)... Vt. (PRWEB) August 28, 2014 ... testing around the world is available from Strategic ... diagnostics companies. “ Industrial Microbiology Market Review, Fourth ... Industrial Market ” (IMMR—4) tracks and compares microbiology ... in North America, Europe and Asia, and forecasts ...
(Date:8/28/2014)... 2014 Supplementing their complete line ... for Eppendorf Safe Lock Centrifuge Tubes . ... highest quality tubes at an affordable price. Eppendorf ... doing chemical, medical, pharmaceutical, and life science research ... regularly able to afford Eppendorf products. , Eppendorf ...
(Date:8/27/2014)... Green & Grow Inc. (GGI) has ... and secured Otter Capital as a significant new partner. ... of GGI’s Agriplier™ technology, building on recent compelling field ... our first meeting, we have been impressed with Otter ... said Alan Sobba, President and CEO of GGI. “We ...
Breaking Biology Technology:Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 32 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 3Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 2Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 3Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 3
... 14 Transgenomic, Inc. (the,"Company") (OTC Bulletin Board: TBIO) ... 2007. The Company,s financial results are,presented in the tables ... reported a net profit of $0.2 million or $0.00 ... to a net loss of $0.4 million or,$0.01 per ...
... Board of Directors,meeting held today, the Directors declared ... dividend is payable on September 14, 2007 to,shareholders ... Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and ... and kits,are used in scientific and genomic research, ...
... Quarter Last Year, - 17 Percent Quarter-to-Quarter Revenue Gain Evidences Start of Turnaround ... for Core Business ... - DelSite Signs Additional Agreements, IRVING, Texas, Aug. 14 Carrington,Laboratories, ... $5.6 million, compared to $6.5 million in the year ago,period. The revenue in the ...
Cached Biology Technology:Transgenomic, Inc. Reports Second Quarter 2007 Results 2Transgenomic, Inc. Reports Second Quarter 2007 Results 3Transgenomic, Inc. Reports Second Quarter 2007 Results 4Transgenomic, Inc. Reports Second Quarter 2007 Results 5Transgenomic, Inc. Reports Second Quarter 2007 Results 6Transgenomic, Inc. Reports Second Quarter 2007 Results 7Transgenomic, Inc. Reports Second Quarter 2007 Results 8Carrington Reports Second Quarter 2007 Results 2Carrington Reports Second Quarter 2007 Results 3Carrington Reports Second Quarter 2007 Results 4Carrington Reports Second Quarter 2007 Results 5Carrington Reports Second Quarter 2007 Results 6Carrington Reports Second Quarter 2007 Results 7
...
cysteine and glycine-rich protein 2,...
... Antitumour agent and DNA-topoisomersae II inhibitor (IC50 = ... C 29 H 32 O 13 ... Store at: RT ... Solubility: Soluble to 100 ...
HSPBP1 Antibody...
Biology Products: